Right now I'm slated to attend an optional Genomic Health Pt Advocate meeting that scholorship advocates were invited to Thursday night . I am looking over the itinerary of symposium events and came across this description below for "Her2: Applying the latest developments to clinical practice". I'm considering the possibility of perhaps switching to it although it looks totally geared to physican's reaching a consensus of the best treatment plan for Her2 patient cases in small discussion groups. Seating is limited and registration is ahead of time on-line. Have you guys ever attended one of these small group discussion formats? Are they suitable for non-physican's to just listen in on? While I'd find it interesting, it's not like I'm an oncologist with a lot to contribute to small group discussion.
Any of you guys going to this? The Hot Topic mentoring session will be at the Convention center right before this, finishing up at 7:30 PM and the other meetings beginning at either 7:30 or 8 PM at the Grand Hyatt and Marriot Rivercenter. I know there are shuttle buses running frequently between hotels. Are the hotels pretty close together and reasonable to get to one meeting to another at a different hotel pretty quickly?
http://clinicaloptions.com/Oncology/...bs/Agenda.aspx
Open Satellite Event Thursday 7:30 - 10 PM
Event Overview
Location:
Marriott Rivercenter
Salon E, Third Floor
101 Bowie Street
San Antonio, Texas
Join us in San Antonio for this important educational event.
Interactive Symposium Format
A leading expert will introduce each case to help kick off your small group discussion on the optimal clinical management of patients with HER2-positive breast cancer.
One iPad will be available at each table to use as a group (to view details of the case as well as other tools to augment your discussions).
Your table will be asked to reach a consensus on how to manage the case and then submit your vote via the iPad. You will have the opportunity to discuss your table’s approach to the case with the larger group.
A distinguished panel of breast cancer experts will then briefly discuss the case and the approach they would take.
Agenda
Didactic Presentation 1: HER2 Testing and Current Knowledge on the Biology of HER2-Positive Tumors (15 min)
•Small group and faculty panel case discussions on HER2 testing and interpretation (15 min)
Didactic Presentation 2: State of the Art in Treating Advanced and Metastatic HER2-Positive Breast Cancer (15 min)
•Small group and faculty panel case discussions; selecting therapy for HER2-positive breast cancer (30 min)
Didactic Presentation 3: Research Highlights: New Agents and Therapeutic Strategies for HER2-Positive Breast Cancer (20 min)
•Small group and faculty panel discussions (10 min)
Question and Answer Session (15 min)
Event Date Details
Thursday, December 6, 2012
7:30 PM - 8:00 PM Registration and Dinner
8:00 PM - 10:00 PM Symposium